Michael Grandal

Michael Grandal is a Principal Scientist at Novo Nordisk since February 2022, with an extensive background in biomedicine. Prior to this role, Michael served as a Principal Scientist, Team Manager, and Senior Scientist at Symphogen from July 2012 to January 2022. Michael's career also includes a postdoctoral position at Novo Nordisk A/S from November 2010 to July 2012 and significant academic experience at Panum Institute, where Michael held various positions including postdoctoral researcher, PhD candidate, and master's student from August 2002 to October 2010. Additionally, Michael briefly served as a postdoctoral researcher at Oslo universitetssykehus HF in 2007. Michael holds a Cand Scient degree in Human Biology from the University of Copenhagen.